Annual Total Expenses
$1.22 B
-$14.90 M-1.20%
31 December 2023
Summary:
Emergent BioSolutions annual total expenses is currently $1.22 billion, with the most recent change of -$14.90 million (-1.20%) on 31 December 2023. During the last 3 years, it has risen by +$200.80 million (+19.62%). EBS annual total expenses is now -2.53% below its all-time high of $1.26 billion, reached on 31 December 2021.EBS Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$219.30 M
-$205.10 M-48.33%
30 September 2024
Summary:
Emergent BioSolutions quarterly total expenses is currently $219.30 million, with the most recent change of -$205.10 million (-48.33%) on 30 September 2024. Over the past year, it has dropped by -$68.60 million (-23.83%). EBS quarterly total expenses is now -48.33% below its all-time high of $424.40 million, reached on 30 June 2024.EBS Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.2% | -23.8% |
| 3 y3 years | +19.6% | -36.8% |
| 5 y5 years | +98.9% | +6.7% |
EBS Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.5% | +19.6% | -48.3% | at low |
| 5 y | 5 years | -2.5% | +98.9% | -48.3% | +20.8% |
| alltime | all time | -2.5% | +2903.1% | -48.3% | +2532.1% |
Emergent BioSolutions Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $219.30 M(-48.3%) |
| June 2024 | - | $424.40 M(+68.0%) |
| Mar 2024 | - | $252.60 M(-19.5%) |
| Dec 2023 | $1.22 B(-1.2%) | $313.70 M(+9.0%) |
| Sept 2023 | - | $287.90 M(-9.3%) |
| June 2023 | - | $317.50 M(+4.0%) |
| Mar 2023 | - | $305.40 M(-17.8%) |
| Dec 2022 | $1.24 B(-1.3%) | $371.70 M(+38.8%) |
| Sept 2022 | - | $267.80 M(-12.9%) |
| June 2022 | - | $307.40 M(+5.5%) |
| Mar 2022 | - | $291.50 M(-10.5%) |
| Dec 2021 | $1.26 B(+22.7%) | $325.60 M(-6.1%) |
| Sept 2021 | - | $346.80 M(-3.0%) |
| June 2021 | - | $357.60 M(+58.0%) |
| Mar 2021 | - | $226.30 M(-24.3%) |
| Dec 2020 | $1.02 B(+17.7%) | $299.10 M(+0.4%) |
| Sept 2020 | - | $298.00 M(+21.6%) |
| June 2020 | - | $245.10 M(+35.0%) |
| Mar 2020 | - | $181.50 M(-29.8%) |
| Dec 2019 | $869.40 M(+41.2%) | $258.50 M(+25.8%) |
| Sept 2019 | - | $205.50 M(-1.8%) |
| June 2019 | - | $209.20 M(+6.7%) |
| Mar 2019 | - | $196.10 M(-15.9%) |
| Dec 2018 | $615.60 M(+68.2%) | $233.10 M(+73.8%) |
| Sept 2018 | - | $134.10 M(-2.0%) |
| June 2018 | - | $136.90 M(+22.9%) |
| Mar 2018 | - | $111.40 M(-10.7%) |
| Dec 2017 | $366.10 M(+52.6%) | $124.73 M(+46.0%) |
| Sept 2017 | - | $85.44 M(+19.9%) |
| June 2017 | - | $71.24 M(-15.9%) |
| Mar 2017 | - | $84.69 M(+59.0%) |
| Dec 2016 | $239.90 M(+4.1%) | $53.25 M(-29.9%) |
| Sept 2016 | - | $75.93 M(+25.4%) |
| June 2016 | - | $60.53 M(+20.6%) |
| Mar 2016 | - | $50.18 M(-28.1%) |
| Dec 2015 | $230.42 M | $69.78 M(+6.2%) |
| Sept 2015 | - | $65.69 M(-5.4%) |
| June 2015 | - | $69.43 M(+18.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $58.84 M(+242.2%) |
| Dec 2014 | $223.60 M(+3.9%) | $17.20 M(-72.6%) |
| Sept 2014 | - | $62.86 M(-21.0%) |
| June 2014 | - | $79.59 M(+24.5%) |
| Mar 2014 | - | $63.95 M(+2.5%) |
| Dec 2013 | $215.12 M(+22.0%) | $62.38 M(+7.3%) |
| Sept 2013 | - | $58.15 M(+14.3%) |
| June 2013 | - | $50.88 M(+16.4%) |
| Mar 2013 | - | $43.71 M(-13.1%) |
| Dec 2012 | $176.31 M(+3.5%) | $50.31 M(+13.9%) |
| Sept 2012 | - | $44.19 M(-0.7%) |
| June 2012 | - | $44.51 M(+19.3%) |
| Mar 2012 | - | $37.30 M(-513.6%) |
| Dec 2011 | $170.31 M(-4.2%) | -$9.02 M(-115.7%) |
| Sept 2011 | - | $57.35 M(-15.6%) |
| June 2011 | - | $67.93 M(+25.7%) |
| Mar 2011 | - | $54.04 M(+61.3%) |
| Dec 2010 | $177.82 M(-8.6%) | $33.49 M(-37.3%) |
| Sept 2010 | - | $53.38 M(+12.8%) |
| June 2010 | - | $47.33 M(+8.5%) |
| Mar 2010 | - | $43.62 M(-12.2%) |
| Dec 2009 | $194.64 M(+31.0%) | $49.68 M(+5.2%) |
| Sept 2009 | - | $47.22 M(-6.5%) |
| June 2009 | - | $50.48 M(+6.8%) |
| Mar 2009 | - | $47.25 M(+35.4%) |
| Dec 2008 | $148.63 M(-0.8%) | $34.90 M(-15.4%) |
| Sept 2008 | - | $41.26 M(+0.8%) |
| June 2008 | - | $40.93 M(+29.7%) |
| Mar 2008 | - | $31.55 M(-32.1%) |
| Dec 2007 | $149.82 M(+31.2%) | $46.48 M(+18.5%) |
| Sept 2007 | - | $39.22 M(+23.2%) |
| June 2007 | - | $31.84 M(-1.4%) |
| Mar 2007 | - | $32.28 M(-24.9%) |
| Dec 2006 | $114.23 M(+38.0%) | $42.99 M(+34.4%) |
| Sept 2006 | - | $31.98 M |
| Dec 2005 | $82.78 M(+17.3%) | - |
| Dec 2004 | $70.54 M(+73.0%) | - |
| Dec 2002 | $40.77 M | - |
FAQ
- What is Emergent BioSolutions annual total expenses?
- What is the all time high annual total expenses for Emergent BioSolutions?
- What is Emergent BioSolutions annual total expenses year-on-year change?
- What is Emergent BioSolutions quarterly total expenses?
- What is the all time high quarterly total expenses for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly total expenses year-on-year change?
What is Emergent BioSolutions annual total expenses?
The current annual total expenses of EBS is $1.22 B
What is the all time high annual total expenses for Emergent BioSolutions?
Emergent BioSolutions all-time high annual total expenses is $1.26 B
What is Emergent BioSolutions annual total expenses year-on-year change?
Over the past year, EBS annual total expenses has changed by -$14.90 M (-1.20%)
What is Emergent BioSolutions quarterly total expenses?
The current quarterly total expenses of EBS is $219.30 M
What is the all time high quarterly total expenses for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly total expenses is $424.40 M
What is Emergent BioSolutions quarterly total expenses year-on-year change?
Over the past year, EBS quarterly total expenses has changed by -$68.60 M (-23.83%)